Texas 2025 89th Regular

Texas House Bill HB4882 Introduced / Fiscal Note

Filed 03/13/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             April 13, 2025       TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB4882 by Shofner (Relating to newborn or infant testing for congenital cytomegalovirus.), As Introduced     Estimated Two-year Net Impact to General Revenue Related Funds for HB4882, As Introduced: a negative impact of ($435,790) through the biennium ending August 31, 2027. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill. General Revenue-Related Funds, Five- Year Impact: Fiscal Year Probable Net Positive/(Negative) Impact toGeneral Revenue Related Funds2026($195,556)2027($240,234)2028($240,674)2029($241,040)2030($241,414)All Funds, Five-Year Impact: Fiscal Year Probable Savings/(Cost) fromGeneral Revenue Fund1 Change in Number of State Employees from FY 20252026($195,556)2.02027($240,234)2.02028($240,674)2.02029($241,040)2.02030($241,414)2.0 Fiscal AnalysisThe bill would require certified birthing facilities to conduct a test for congenital cytomegalovirus (CMV) on each newborn or infant born at the facility before being discharged from the facility unless declined by the parent, a transfer to another facility before a test is performed, a test was previously conducted, or the newborn was discharged from birthing facility not more than ten hours after birth and a referral for the newborn was made to a certified program at another birthing facility or operated by a physician or other healthcare provider. The Department of State Health Services (DSHS) would be required to maintain data and information on each newborn or infant who receives a CMV test under the bill.

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
April 13, 2025



TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB4882 by Shofner (Relating to newborn or infant testing for congenital cytomegalovirus.), As Introduced

TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB4882 by Shofner (Relating to newborn or infant testing for congenital cytomegalovirus.), As Introduced



Honorable Gary VanDeaver, Chair, House Committee on Public Health

Honorable Gary VanDeaver, Chair, House Committee on Public Health

Jerry McGinty, Director, Legislative Budget Board

Jerry McGinty, Director, Legislative Budget Board

HB4882 by Shofner (Relating to newborn or infant testing for congenital cytomegalovirus.), As Introduced

HB4882 by Shofner (Relating to newborn or infant testing for congenital cytomegalovirus.), As Introduced

Estimated Two-year Net Impact to General Revenue Related Funds for HB4882, As Introduced: a negative impact of ($435,790) through the biennium ending August 31, 2027. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.

Estimated Two-year Net Impact to General Revenue Related Funds for HB4882, As Introduced: a negative impact of ($435,790) through the biennium ending August 31, 2027. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.

The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.

General Revenue-Related Funds, Five- Year Impact:


2026 ($195,556)
2027 ($240,234)
2028 ($240,674)
2029 ($241,040)
2030 ($241,414)



All Funds, Five-Year Impact:


2026 ($195,556) 2.0
2027 ($240,234) 2.0
2028 ($240,674) 2.0
2029 ($241,040) 2.0
2030 ($241,414) 2.0



Fiscal Analysis

The bill would require certified birthing facilities to conduct a test for congenital cytomegalovirus (CMV) on each newborn or infant born at the facility before being discharged from the facility unless declined by the parent, a transfer to another facility before a test is performed, a test was previously conducted, or the newborn was discharged from birthing facility not more than ten hours after birth and a referral for the newborn was made to a certified program at another birthing facility or operated by a physician or other healthcare provider. The Department of State Health Services (DSHS) would be required to maintain data and information on each newborn or infant who receives a CMV test under the bill.

The Department of State Health Services (DSHS) would be required to maintain data and information on each newborn or infant who receives a CMV test under the bill.

Methodology

Based on information provided by DSHS, this analysis assumes DSHS would require 2.0 additional full-time equivalent positions (FTEs) to implement requirements under the bill. This includes a Program Specialist II (1.0 FTE) to provide client and technology support for the new CMV newborn screening follow up program, maintain data collection on CMV tests, and to conduct administrative duties; and a Program Specialist II (1.0 FTE) to be the team lead for CMV follow up team, provide follow up on complex cases and technical assistance to screening programs, maintain the data collection system on CMV tests, and conduct data analyses to ensure data fidelity. Salaries, benefits, and related FTE costs for the new positions would total $195,556 from the General Revenue Fund in fiscal year 2026 and $240,234 from the General Revenue Fund in fiscal year 2027. The lower cost in fiscal year 2026 is attributable to a later start date for the new positions assumed in the first fiscal year.According to the Health and Human Services Commission, any costs associated with the bill can be absorbed within existing resources.

According to the Health and Human Services Commission, any costs associated with the bill can be absorbed within existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 529 Health and Human Services Commission, 537 State Health Services, Department of



529 Health and Human Services Commission, 537 State Health Services, Department of

LBB Staff: b > td > JMc, NPe, ER, APA



JMc, NPe, ER, APA